ATE460407T1 - Kristalline formen von duloxetin als freie base - Google Patents
Kristalline formen von duloxetin als freie baseInfo
- Publication number
- ATE460407T1 ATE460407T1 AT05744361T AT05744361T ATE460407T1 AT E460407 T1 ATE460407 T1 AT E460407T1 AT 05744361 T AT05744361 T AT 05744361T AT 05744361 T AT05744361 T AT 05744361T AT E460407 T1 ATE460407 T1 AT E460407T1
- Authority
- AT
- Austria
- Prior art keywords
- duloxetine
- free base
- crystalline forms
- crystalline
- forms
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
- C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Pain & Pain Management (AREA)
- Child & Adolescent Psychology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Steroid Compounds (AREA)
- Crystals, And After-Treatments Of Crystals (AREA)
- Analysing Materials By The Use Of Radiation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0410470.9A GB0410470D0 (en) | 2004-05-11 | 2004-05-11 | Pharmaceutical compound and polymorphs thereof |
| PCT/GB2005/001825 WO2005108386A1 (en) | 2004-05-11 | 2005-05-11 | Crystalline forms of duloxetine free base |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE460407T1 true ATE460407T1 (de) | 2010-03-15 |
Family
ID=32526812
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT05744361T ATE460407T1 (de) | 2004-05-11 | 2005-05-11 | Kristalline formen von duloxetin als freie base |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US7951837B2 (de) |
| EP (1) | EP1745031B1 (de) |
| JP (1) | JP5285272B2 (de) |
| KR (1) | KR20070011593A (de) |
| AR (1) | AR049093A1 (de) |
| AT (1) | ATE460407T1 (de) |
| AU (1) | AU2005240839B2 (de) |
| CA (1) | CA2566092C (de) |
| DE (1) | DE602005019873D1 (de) |
| ES (1) | ES2340297T3 (de) |
| GB (1) | GB0410470D0 (de) |
| NZ (1) | NZ551125A (de) |
| PA (1) | PA8632501A1 (de) |
| WO (1) | WO2005108386A1 (de) |
| ZA (1) | ZA200609205B (de) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007523213A (ja) | 2004-12-23 | 2007-08-16 | テバ ファーマシューティカル インダストリーズ リミティド | 医薬的に許容できるデュロキセチンの塩及びその中間体の調製方法 |
| US7534900B2 (en) | 2005-03-14 | 2009-05-19 | Teva Pharmaceutical Industries Ltd | Process for the purification of duloxetine hydrochloride |
| WO2007038253A2 (en) | 2005-09-22 | 2007-04-05 | Teva Pharmaceutical Industries Ltd. | Dnt-maleate and methods of preparation thereof |
| EP1863782A1 (de) * | 2005-12-05 | 2007-12-12 | Teva Pharmaceutical Industries Ltd. | 2-(n-methyl-propanamin)-3-(2-naphthol) thiophen, eine verunreinigung von duloxetin hydrochlorid |
| WO2007119114A2 (en) * | 2005-12-12 | 2007-10-25 | Medichem, S.A. | Improved synthesis and preparations of duloxetine salts |
| CZ299270B6 (cs) | 2006-01-04 | 2008-06-04 | Zentiva, A. S. | Zpusob výroby hydrochloridu (S)-N-methyl-3-(1-naftyloxy)-3-(2-thienyl)propylaminu |
| EP1820800A1 (de) | 2006-02-17 | 2007-08-22 | KRKA, tovarna zdravil, d.d., Novo mesto | Kristalline Formen von Duloxetine hydrochlorid und Verfahren zu deren Herstellung |
| WO2007134168A2 (en) * | 2006-05-10 | 2007-11-22 | Dr. Reddy's Laboratories Ltd. | Process for preparing duloxetine |
| KR20090005237A (ko) * | 2006-05-22 | 2009-01-12 | 테바 파마슈티컬 인더스트리즈 리미티드 | 둘록세틴 염산염 지연 방출형 제제 |
| CN101448815A (zh) * | 2006-05-23 | 2009-06-03 | 特瓦制药工业有限公司 | 度洛西汀hci多晶型物 |
| GB0612508D0 (en) * | 2006-06-23 | 2006-08-02 | Arrow Int Ltd | Crystalline duloxetine hydrochloride |
| GB0612506D0 (en) * | 2006-06-23 | 2006-08-02 | Arrow Int Ltd | Crystalline duloxetine hydrochloride |
| GB0612509D0 (en) * | 2006-06-23 | 2006-08-02 | Arrow Int Ltd | Crystalline duloxetine hydrochloride |
| CZ300116B6 (cs) * | 2006-12-05 | 2009-02-11 | Zentiva, A. S. | Zpusob cištení hydrochloridu (S)-N-methyl-3-(1-naftyloxy)-3-(2-thienyl)propylaminu |
| US20090226517A1 (en) * | 2008-02-06 | 2009-09-10 | Vinita Umashankar Vyas | Pharmaceutical formulations comprising duloxetine |
| CA2754141A1 (en) | 2009-03-13 | 2010-09-16 | Alembic Pharmaceuticals Limited | A process for the preparation of duloxetine hydrochloride |
| CZ304602B6 (cs) * | 2009-09-02 | 2014-07-30 | Zentiva, K. S. | Způsob krystalizace hydrochloridu (S)-N-methyl-3-(1-naftyloxy)-3-(2-thienyl)propylaminu (hydrochloridu duloxetinu) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4956388A (en) * | 1986-12-22 | 1990-09-11 | Eli Lilly And Company | 3-aryloxy-3-substituted propanamines |
| KR880007433A (ko) * | 1986-12-22 | 1988-08-27 | 메리 앤 터커 | 3-아릴옥시-3-치환된 프로판아민 |
| US5362886A (en) * | 1993-10-12 | 1994-11-08 | Eli Lilly And Company | Asymmetric synthesis |
| US5508276A (en) * | 1994-07-18 | 1996-04-16 | Eli Lilly And Company | Duloxetine enteric pellets |
-
2004
- 2004-05-11 GB GBGB0410470.9A patent/GB0410470D0/en not_active Ceased
-
2005
- 2005-05-11 CA CA2566092A patent/CA2566092C/en not_active Expired - Fee Related
- 2005-05-11 AT AT05744361T patent/ATE460407T1/de not_active IP Right Cessation
- 2005-05-11 JP JP2007512342A patent/JP5285272B2/ja not_active Expired - Fee Related
- 2005-05-11 KR KR1020067026003A patent/KR20070011593A/ko not_active Withdrawn
- 2005-05-11 AU AU2005240839A patent/AU2005240839B2/en not_active Ceased
- 2005-05-11 DE DE602005019873T patent/DE602005019873D1/de not_active Expired - Lifetime
- 2005-05-11 US US11/568,784 patent/US7951837B2/en not_active Expired - Fee Related
- 2005-05-11 EP EP05744361A patent/EP1745031B1/de not_active Expired - Lifetime
- 2005-05-11 WO PCT/GB2005/001825 patent/WO2005108386A1/en not_active Ceased
- 2005-05-11 NZ NZ551125A patent/NZ551125A/en not_active IP Right Cessation
- 2005-05-11 ES ES05744361T patent/ES2340297T3/es not_active Expired - Lifetime
- 2005-05-11 AR ARP050101918A patent/AR049093A1/es unknown
- 2005-05-11 PA PA20058632501A patent/PA8632501A1/es unknown
-
2006
- 2006-11-06 ZA ZA2006/09205A patent/ZA200609205B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PA8632501A1 (es) | 2006-07-03 |
| DE602005019873D1 (de) | 2010-04-22 |
| AU2005240839A1 (en) | 2005-11-17 |
| WO2005108386A1 (en) | 2005-11-17 |
| CA2566092C (en) | 2013-12-10 |
| US20070167513A1 (en) | 2007-07-19 |
| NZ551125A (en) | 2010-08-27 |
| KR20070011593A (ko) | 2007-01-24 |
| US7951837B2 (en) | 2011-05-31 |
| AR049093A1 (es) | 2006-06-28 |
| ZA200609205B (en) | 2008-08-27 |
| EP1745031B1 (de) | 2010-03-10 |
| JP5285272B2 (ja) | 2013-09-11 |
| CA2566092A1 (en) | 2005-11-17 |
| JP2007537223A (ja) | 2007-12-20 |
| AU2005240839B2 (en) | 2012-02-02 |
| ES2340297T3 (es) | 2010-06-01 |
| GB0410470D0 (en) | 2004-06-16 |
| EP1745031A1 (de) | 2007-01-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE602005012267D1 (de) | N von geräten | |
| DE602005019873D1 (de) | Kristalline formen von duloxetin als freie base | |
| FR2872069B1 (fr) | Vibrateur vertical | |
| ATE414693T1 (de) | Neuartige cis-imidazoline | |
| ATE491700T1 (de) | KRISTALLINE FORMEN VON 1-CHLORO-4-(ß-D- | |
| EP1769345A4 (de) | Programmstatuswiedergabe | |
| DE60321190D1 (de) | Knopf | |
| DE502005007457D1 (de) | Mikroemulsionen | |
| DE602005027610D1 (de) | Nmr-gyroskop | |
| DE602005012984D1 (de) | Suspensionspolymerisationsverfahren | |
| DE602005019199D1 (de) | Suspensionspolymerisationsverfahren | |
| DE602005016475D1 (de) | Knopf | |
| DE502004009754D1 (de) | Tourbillon | |
| FR2868359B1 (fr) | Suspension du type a jambe | |
| DE602005019087D1 (de) | Suspensionspolymerisationsverfahren | |
| DE502004009022D1 (de) | Pendelstütze | |
| ATE499348T1 (de) | Stabiler polymorph von bifeprunoxmesilat | |
| SE0401271L (sv) | Målningsklocka | |
| SE0402103D0 (sv) | Novel compounds | |
| FIU20040005U0 (fi) | Poraniskan ylävaste | |
| FIU20040172U0 (fi) | Ripustusvarsi | |
| ITRI20050001U1 (it) | Kit dell'amatriciana | |
| SK3683U (sk) | Pružná tkanina na cvičné účely | |
| SE0302006D0 (sv) | New Microemulsions | |
| SE0402822D0 (sv) | A new salt |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |